The Super Bowl Ad That Promises the American Dream
The healthcare divide is a growing concern in the US, and a new ad campaign is stirring up emotions. This year's Super Bowl viewers are in for a thought-provoking ad from Hims & Hers, a telehealth company with a bold statement: "Rich people live longer." But is this a promise or a provocation?
The ad parodies the wellness routines of the wealthy, from red-light baths to rocket-launching cowboys, alluding to real-life figures like Bryan Johnson and Jeff Bezos. It hints at the stark contrast between the elite's access to healthcare and the average American's struggle. Dan Kenger, Hims & Hers' design chief, confirms the ad's symbolism, but the message is clear: the rich get the best, so why can't you?
Hims & Hers, known for weight loss and hair restoration, is rebranding itself as a gateway to exclusive healthcare. They offer on-demand concierge doctors and personalized treatments, a stark contrast to the reactive healthcare system many Americans face. While their services may not be as glamorous as a facelift, they emphasize accessibility at a price.
Here's where it gets controversial: Telehealth platforms like Hims & Hers provide a direct line to prescriptions, often for controlled substances. They bypass high-cost brand-name drugs by offering compounded versions, which are cheaper but not FDA-approved. This practice has raised concerns about patient safety and the potential for overprescription. In fact, the DOJ is investigating Hims & Hers for selling compounded GLP-1 pills, a move that has the medical community on alert.
Last year's Hims & Hers Super Bowl ad focused on GLP-1s for weight loss, blaming the system for America's obesity crisis. The ad sparked a mix of emotions, with some feeling envy towards celebrities using these drugs. Now, the demand for medications like testosterone and peptides is soaring, fueled by endorsements from the rich and famous. Hims & Hers has responded by launching a low-testosterone program and acquiring a peptide facility to create personalized drugs.
The company's language mimics the exclusivity of concierge treatments, but in reality, it often involves adjusting doses or adding ingredients to brand-name medications. The FDA's recent announcement highlights the risks of these compounded drugs, which may not contain the necessary active ingredients. Hims & Hers has since agreed to stop selling compounded GLP-1 pills, but the debate continues.
The ad's choice of narrator, rapper Common, known for his socially conscious music, adds a layer of authenticity to the message. It resonates with the 71% of Americans worried about healthcare costs, according to Pew Research. Yet, the irony is that many Americans emulate the wellness trends of billionaires, from peptides to keto diets, despite the questionable benefits.
Hims & Hers' diagnosis of the wealth gap in healthcare is spot-on. However, their proposed solution raises questions. Are they truly delivering justice, or are they contributing to a system that prioritizes profit over patient safety? The controversy surrounding telehealth platforms and their role in healthcare accessibility is a hot topic. What do you think? Is Hims & Hers a game-changer or a contributor to the problem?
